Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

RILUZOLE

RILUZOLE

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview RILUZOLE is listed in Drugs@FDA under application 206045 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient RILUZOLE Form and strength TABLET;ORAL - 50MG Sponsor KENTON Submission history Latest submission status date: 2023-10-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview RILUZOLE is listed in Drugs@FDA under application 206045 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient RILUZOLE Form and strength TABLET;ORAL - 50MG Sponsor KENTON Submission history Latest submission status date: 2023-10-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.